Embryo Invest ApS: Financial statements 2024
CVR: 42047864
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Embryo Invest ApS (CVR 42047864) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -16,000 and a net result of DKK 8,570,903 compared with DKK 5,038,180 the year before. Equity in the 2024 report amounted to DKK 11,718,410. The solvency ratio was 68.8%.
- Gross Profit
- DKK -16,000
- Profit/Loss
- DKK 8,570,903
- Equity
- DKK 11,718,410
- Total Assets
- DKK 17,029,211
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -16K | 8.6M | 11.7M | 0 |
| 2023 | - | -35K | 5M | 3.3M | 0 |
| 2022 | - | -19K | -8M | -1.7M | 0 |
| 2021 | - | -5K | 6.3M | 6.3M | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Embryo Invest ApS has published its annual report for 2023. Gross profit came to DKK -35,375, and the net result was DKK 5,038,180.
As of June 3, 2024, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Embryo Invest ApS.
About Embryo Invest ApS
Embryo Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Cathrine Olesen Emborg. The company is owned by Cathrine Olesen Emborg. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -5,449 and a net result of DKK 840,493 compared with DKK 8,570,903 the year before. Equity in the 2025 report amounted to DKK 12,423,903.
